220 related articles for article (PubMed ID: 35707986)
1. Transforming growth factor-β signalling pathway in tendon healing.
Li Y; Liu X; Liu X; Peng Y; Zhu B; Guo S; Wang C; Wang D; Li S
Growth Factors; 2022 Aug; 40(3-4):98-107. PubMed ID: 35707986
[TBL] [Abstract][Full Text] [Related]
2. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-β/Smad ubiquitin regulatory factor-2 signalling.
Zhang Z; Gao X; He Y; Kang Y; Jin F; Li Y; Li T; Wei Z; Li S; Cai W; Mao N; Wang S; Liu H; Yang F; Xu H; Yang J
J Cell Mol Med; 2021 Dec; 25(24):11290-11299. PubMed ID: 34783198
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
5. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
6. Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling.
Kamato D; Do BH; Osman N; Ross BP; Mohamed R; Xu S; Little PJ
Cell Mol Life Sci; 2020 Jan; 77(2):243-251. PubMed ID: 31407020
[TBL] [Abstract][Full Text] [Related]
7. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Meng XM; Chung AC; Lan HY
Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
[TBL] [Abstract][Full Text] [Related]
8. SETD2 deficiency promotes renal fibrosis through the TGF-β/Smad signalling pathway in the absence of VHL.
Liu C; Ni L; Li X; Rao H; Feng W; Zhu Y; Zhang W; Ma C; Xu Y; Gui L; Wang Z; Aji R; Xu J; Gao WQ; Li L
Clin Transl Med; 2023 Nov; 13(11):e1468. PubMed ID: 37933774
[TBL] [Abstract][Full Text] [Related]
9. TGF-β isoforms inhibit hepatitis C virus propagation in transforming growth factor beta/SMAD protein signalling pathway dependent and independent manners.
Zou LL; Li JR; Li H; Tan JL; Wang MX; Liu NN; Gao RM; Yan HY; Wang XK; Dong B; Li YH; Peng ZG
J Cell Mol Med; 2021 Apr; 25(7):3498-3510. PubMed ID: 33682288
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.
Walraven M; Beelen RH; Ulrich MM
J Dermatol Sci; 2015 May; 78(2):117-24. PubMed ID: 25795202
[TBL] [Abstract][Full Text] [Related]
11. Role of Smad signaling in kidney disease.
Zhang Y; Wang S; Liu S; Li C; Wang J
Int Urol Nephrol; 2015 Dec; 47(12):1965-75. PubMed ID: 26433882
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
13. Non-Smad TGF-beta signals.
Moustakas A; Heldin CH
J Cell Sci; 2005 Aug; 118(Pt 16):3573-84. PubMed ID: 16105881
[TBL] [Abstract][Full Text] [Related]
14. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-497 elevation or LRG1 knockdown promotes osteoblast proliferation and collagen synthesis in osteoporosis via TGF-β1/Smads signalling pathway.
Gu Z; Xie D; Huang C; Ding R; Zhang R; Li Q; Lin C; Qiu Y
J Cell Mol Med; 2020 Nov; 24(21):12619-12632. PubMed ID: 32975015
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
Lan HY
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
[TBL] [Abstract][Full Text] [Related]
18. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
[TBL] [Abstract][Full Text] [Related]
19. Tendon-derived extracellular matrix induces mesenchymal stem cell tenogenesis via an integrin/transforming growth factor-β crosstalk-mediated mechanism.
Wang D; Pun CCM; Huang S; Tang TCM; Ho KKW; Rothrauff BB; Yung PSH; Blocki AM; Ker EDF; Tuan RS
FASEB J; 2020 Jun; 34(6):8172-8186. PubMed ID: 32301551
[TBL] [Abstract][Full Text] [Related]
20. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
Lan HY
Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]